Clinical Proteomics
News on proteomics applications for clinical use in genetics, genomics, and molecular diagnostics.
Evolving Akoya Biosciences Touts CDx Partnerships at JP Morgan Conference
The Marlborough, Massachusetts-based firm also announced new panels for its PhenoCycler-Fusion and PhenoImager HT spatial analysis platforms.
Texas Research Institute, TGen, OncoHost Partner to ID Lung Cancer Resistance Mechanisms
Collaborators will study the immune profiles and molecular features of NSCLC to better understand patterns of response and resistance to immunotherapy.
For proteomics firms, 2022 marked a reversal from an earlier boom, but the field pushed into emerging areas like single-cell, single-molecule, and spatial analyses.
ProPhase Labs to Acquire Stella Diagnostics Esophageal Cancer Screening Test for $4.5M
The agreement gives ProPhase exclusive global rights to Stella's BE-Smart Esophageal Pre-Cancer screening test and related intellectual property assets.
Precision Oncology Dx Firm Navignostics Raises CHF 7.5 M in Seed Funding From Bruker, Others
The company is developing a system combining single-cell spatial proteomic data with artificial intelligence analysis to guide therapy selection for cancer patients.